The global negative pressure wound therapy market size was valued at US$ 5.9 Bn in 2021 and is expected to touch a valuation of US$ 6.2 Bn in 2022.Further, with rising prevalence of chronic wounds such as diabetic foot ulcers, post-surgical ulcers, and pressure ulcers, and increasing wound care spending, the overall.
Effectiveness of negative pressure wound therapy (NPWT) in treating acute and chronic wounds is a key factor driving its adoption across hospitals, clinics, and homecare settings. The use of NPWT devices in managing closed incisions, where the risk of wound breakdown is higher, is also fuelling the growth of the neg.